Correlogic and JEOL Team to Advance Mass Spectrometry
Correlogic Systems Inc. and JEOL Ltd. announced yesterday they have formalized a yearlong collaboration by signing a research and development agreement to enhance the performance of mass spectrometry in a clinical setting. Specific details of the agreement were not disclosed. Tokyo-based JEOL makes scientific instruments used for R&D in nanotechnology, life sciences, optical communication, forensics and biotechnology. Correlogic, based in Rockville, Md., develops pattern-recognition technologies for use in biomarker discovery, disease detection and new drug discovery.
LATEST NEWS
- Quantinuum Launches 56-Qubit Quantum Computer: Week in Brief: 6/7/2024
Jun 7, 2024
- Atom Computing Lands Investment, Expands Overseas
Jun 7, 2024
- Optogenetic Stimulation Enables Fatigue-Resistant Muscle Control
Jun 6, 2024
- Quandela Launches Pilot Line for Qubit Devices
Jun 6, 2024
- Lattice Semiconductor Adds Interim CEO
Jun 6, 2024
- On-Chip Microcomb Laser Provides Greater Control
Jun 5, 2024
- Flexible, Stretchable Device Addresses Tuning Limitations in Structural Color
Jun 5, 2024
- Fusion Startup Xcimer Raises $100M, Plans Laser Prototype
Jun 4, 2024